ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.
about
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25Persistence of side population cells with high drug efflux capacity in pancreatic cancer.CD133 expression in chemo-resistant Ewing sarcoma cellsHematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells.OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib.Cancer stem cells and side population cells in breast cancer and metastasis.ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patientsHyaluronan regulates cell behavior: a potential niche matrix for stem cellsHyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.Stem cells and aging in the hematopoietic system.ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.Understanding of leukemic stem cells and their clinical implications.Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib.Bone marrow neoplastic niche in leukemia.Age-related Deterioration of Hematopoietic Stem Cells.The role of ATP-binding cassette transporter A2 in childhood acute lymphoblastic leukemia multidrug resistance.Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells.Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.ABC transporters affect the detection of intracellular oxidants by fluorescent probes.Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients.WNT signaling - lung cancer is no exception.Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells.The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance.Mini-P-gp and P-gp Co-Expression in Brown Trout Erythrocytes: A Prospective Blood Biomarker of Aquatic Pollution.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.P-gp expression levels in the erythrocytes of brown trout: a new tool for aquatic sentinel biomarker development.Nanoparticles for Stem-Cell Engineering
P2860
Q27692033-87047AB3-145D-4511-8DF8-6B68B7353C78Q28484919-894CEA64-57E4-48FE-81A0-B85B55DF6073Q33317784-B6E14A86-C076-457C-9320-1756207067DCQ33546702-1CA777E2-0E70-478B-931B-062089286791Q33690881-7DE4B215-642F-4C13-83E8-BEE8DCB37A53Q34774289-E05CAD5C-AAFF-4A4B-99B4-683EC964F1FBQ35038054-AD755C6B-F159-4CD8-8C46-EA17240E43FFQ35193725-11E149DC-9B86-41DE-9C83-FA45E7C08E1AQ35779448-E8E3E178-CE3B-4637-BFA0-1B31F74DD537Q36976346-2FEB05E2-2B90-45AD-8F11-22D020A9A781Q37109225-45572225-809E-4786-AFEA-449AECED3809Q37163624-5CDA5F94-488F-472B-8C87-66B91263252CQ37595188-2FBE282F-289B-46F1-AB5A-F27B188574E9Q37616010-A24F901C-93BF-460B-A36D-792862A7B8F2Q37666618-373A1FB9-9CC4-4398-914C-AB0B3A865F45Q38113416-1A9CAB12-F189-4464-BF73-8B8F14AC01C3Q38125795-06EC44D0-FFE3-4D0E-B60D-33E88B2BF916Q38214091-5296EED7-974A-4B06-9A58-37467CF93868Q38254136-7470EC68-D18F-4A8B-A069-B0C07BB1FA62Q38637968-8DB79304-F4DF-4B40-9CDA-559A9A97F679Q38757530-1ABA6C78-E178-44A4-98E9-3EC8C58705CAQ39013427-2EFA9FC5-2613-4FE5-B355-B1D17A17ADD1Q39137683-383C430B-EEFA-4AFF-945D-8DB2E04501E3Q39543500-B97EA649-75BA-46D6-8294-612A0CD8E715Q39552767-B7DBF431-D6F7-4DA4-BA8B-8D0F76284617Q41613396-A10C8BF5-A15A-42E2-9AC2-791604E40F8DQ41885023-1926C0D0-3196-4730-B1B9-8DC48C53C513Q42090074-65F90035-A32B-4240-8EEE-17DCFEB84DE5Q42938924-2905B539-3E1A-456D-8CF9-527485B07D3EQ43147836-EDCEA520-5738-4ABD-8B78-D2284969BB4DQ47216949-E009E345-9FB4-4A58-A49E-16097C97AAABQ47289144-B8B4A1BD-FF91-4A87-AB82-2CD6EE33DCA4Q50123249-9B80161C-8655-49F9-B96E-FCC1431E1FC2Q53244652-F867DB61-152D-473B-B49E-389642DAF0ABQ57340466-20E5B8FD-FEDF-4FDC-80AE-726BE3AA3B8A
P2860
ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
ATP-binding-cassette transport ...... and chronic myeloid leukemia.
@en
type
label
ATP-binding-cassette transport ...... and chronic myeloid leukemia.
@en
prefLabel
ATP-binding-cassette transport ...... and chronic myeloid leukemia.
@en
P2860
P356
P1433
P1476
ATP-binding-cassette transport ...... and chronic myeloid leukemia.
@en
P2093
Raaijmakers MH
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404859
P577
2007-07-26T00:00:00Z